Published in Transl Psychiatry on September 22, 2015
Antenatal depression, treatment with selective serotonin reuptake inhibitors, and neonatal brain structure: A propensity-matched cohort study. Psychiatry Res (2016) 0.75
Systems Pharmacology Based Study of the Molecular Mechanism of SiNiSan Formula for Application in Nervous and Mental Diseases. Evid Based Complement Alternat Med (2016) 0.75
Genome-wide atlas of gene expression in the adult mouse brain. Nature (2006) 28.02
Genome sequence of the Brown Norway rat yields insights into mammalian evolution. Nature (2004) 24.40
Chronic antidepressant treatment increases neurogenesis in adult rat hippocampus. J Neurosci (2000) 9.12
The catecholamine hypothesis of affective disorders: a review of supporting evidence. Am J Psychiatry (1965) 5.09
Oligodendrocyte dysfunction in schizophrenia and bipolar disorder. Lancet (2003) 4.84
White matter in learning, cognition and psychiatric disorders. Trends Neurosci (2008) 4.72
Early-life blockade of the 5-HT transporter alters emotional behavior in adult mice. Science (2004) 4.31
The developmental role of serotonin: news from mouse molecular genetics. Nat Rev Neurosci (2003) 3.79
The role of the hippocampus in the pathophysiology of major depression. J Psychiatry Neurosci (2004) 2.43
Transcriptional profiling reveals evidence for signaling and oligodendroglial abnormalities in the temporal cortex from patients with major depressive disorder. Mol Psychiatry (2005) 2.41
Claudin-11/OSP-based tight junctions of myelin sheaths in brain and Sertoli cells in testis. J Cell Biol (1999) 2.40
Acceleration of the effect of selected antidepressant drugs in major depression by 5-HT1A antagonists. Trends Neurosci (1996) 2.22
Antidepressant use during pregnancy and childhood autism spectrum disorders. Arch Gen Psychiatry (2011) 2.09
Impact of antidepressant discontinuation after acute bipolar depression remission on rates of depressive relapse at 1-year follow-up. Am J Psychiatry (2003) 1.88
CNTF protection of oligodendrocytes against natural and tumor necrosis factor-induced death. Science (1993) 1.74
A 24-week randomized, double-blind, placebo-controlled study of escitalopram for the prevention of generalized social anxiety disorder. J Clin Psychiatry (2005) 1.61
Fluoxetine and impulsive aggressive behavior in personality-disordered subjects. Arch Gen Psychiatry (1997) 1.59
Can we really accelerate and enhance the selective serotonin reuptake inhibitor antidepressant effect? A randomized clinical trial and a meta-analysis of pindolol in nonresistant depression. J Clin Psychiatry (2010) 1.55
Ciliary neurotrophic factor and leukemia inhibitory factor promote the generation, maturation and survival of oligodendrocytes in vitro. Development (1994) 1.54
Antidepressants and their effect on sleep. Hum Psychopharmacol (2005) 1.48
Ciliary neurotrophic factor (CNTF) enhances myelin formation: a novel role for CNTF and CNTF-related molecules. J Neurosci (2002) 1.45
Antidepressant-induced sexual dysfunction during treatment with fluoxetine, sertraline and trazodone; a randomized controlled trial. Gen Hosp Psychiatry (2014) 1.44
Effects of chronic antidepressant treatments on serotonin transporter function, density, and mRNA level. J Neurosci (1999) 1.42
Fluoxetine prevents oligodendrocyte cell death by inhibiting microglia activation after spinal cord injury. J Neurotrauma (2015) 1.42
Fluoxetine versus other types of pharmacotherapy for depression. Cochrane Database Syst Rev (2005) 1.41
Lasting syndrome of depression produced by reduction in serotonin uptake during postnatal development: evidence from sleep, stress, and behavior. J Neurosci (2008) 1.40
Recurrence of first-episode geriatric depression after discontinuation of maintenance antidepressants. Am J Psychiatry (1999) 1.39
Depression, antidepressants, and the shrinking hippocampus. Proc Natl Acad Sci U S A (2001) 1.37
Antidepressants and violence: problems at the interface of medicine and law. PLoS Med (2006) 1.28
Fluoxetine-induced change in rat brain expression of brain-derived neurotrophic factor varies depending on length of treatment. Neuroscience (2004) 1.27
The role of hippocampus in anxiety: intracerebral infusion studies. Behav Pharmacol (2007) 1.25
Intermittent hypoxia promotes hippocampal neurogenesis and produces antidepressant-like effects in adult rats. J Neurosci (2010) 1.23
Vascular endothelial growth factor signaling is required for the behavioral actions of antidepressant treatment: pharmacological and cellular characterization. Neuropsychopharmacology (2009) 1.21
The role of hippocampus in the pathophysiology of bipolar disorder. Behav Pharmacol (2007) 1.19
How factors secreted from astrocytes impact myelin repair. J Neurosci Res (2011) 1.16
Regulation of 5-HT1A receptor function in brain following agonist or antidepressant administration. Life Sci (2003) 1.13
Perinatal antidepressant exposure alters cortical network function in rodents. Proc Natl Acad Sci U S A (2011) 1.12
Excess of serotonin affects embryonic interneuron migration through activation of the serotonin receptor 6. Mol Psychiatry (2008) 1.11
The age-dependent effects of selective serotonin reuptake inhibitors in humans and rodents: A review. Prog Neuropsychopharmacol Biol Psychiatry (2010) 1.11
Neurogenesis in the dentate gyrus depends on ciliary neurotrophic factor and signal transducer and activator of transcription 3 signaling. Stem Cells (2009) 1.08
Inactivation of 5-HT(2C) receptors potentiates consequences of serotonin reuptake blockade. Neuropsychopharmacology (2004) 1.06
Chronic fluoxetine treatment induces brain region-specific upregulation of genes associated with BDNF-induced long-term potentiation. Neural Plast (2007) 1.05
Regulation of editing and expression of glutamate alpha-amino-propionic-acid (AMPA)/kainate receptors by antidepressant drugs. Biol Psychiatry (2006) 1.05
Long-lasting behavioural and molecular alterations induced by early postnatal fluoxetine exposure are restored by chronic fluoxetine treatment in adult mice. Eur Neuropsychopharmacol (2008) 1.03
Fluoxetine exerts age-dependent effects on behavior and amygdala neuroplasticity in the rat. PLoS One (2011) 1.01
Hippocampal volume reduction and history of aggressive behaviour in patients with borderline personality disorder. Psychiatry Res (2007) 0.99
Efficacy of paroxetine for relapse prevention in social anxiety disorder: a 24-week study. Arch Gen Psychiatry (2002) 0.97
Ciliary neurotrophic factor enhances the rate of oligodendrocyte generation. Mol Cell Neurosci (1996) 0.97
Function of tetraspan proteins in the myelin sheath. Curr Opin Neurobiol (2000) 0.94
Disrupted compaction of CNS myelin in an OSP/Claudin-11 and PLP/DM20 double knockout mouse. Mol Cell Neurosci (2005) 0.94
A novel rat tetraspan protein in cells of the oligodendrocyte lineage. J Neurochem (1999) 0.94
Abnormalities of white matter microstructure in unmedicated obsessive-compulsive disorder and changes after medication. PLoS One (2012) 0.94
Adaptations in pre- and postsynaptic 5-HT1A receptor function and cocaine supersensitivity in serotonin transporter knockout rats. Psychopharmacology (Berl) (2008) 0.93
microRNAs as novel antidepressant targets: converging effects of ketamine and electroconvulsive shock therapy in the rat hippocampus. Int J Neuropsychopharmacol (2013) 0.92
5-HT7 receptor antagonists as a new class of antidepressants. Drug News Perspect (2007) 0.92
Chronic fluoxetine treatment partly attenuates the long-term anxiety and depressive symptoms induced by MDMA ('Ecstasy') in rats. Neuropsychopharmacology (2004) 0.92
Genetic and pharmacological manipulations of the serotonergic system in early life: neurodevelopmental underpinnings of autism-related behavior. Front Cell Neurosci (2013) 0.92
Endogenous CNTF mediates stroke-induced adult CNS neurogenesis in mice. Neurobiol Dis (2012) 0.91
Effects of fluoxetine treatment on striatal dopamine transporter binding and cerebrospinal fluid insulin-like growth factor-1 in children with autism. Neuropediatrics (2011) 0.91
Fluoxetine administration to pregnant rats increases anxiety-related behavior in the offspring. Psychopharmacology (Berl) (2011) 0.91
Chronic SSRI stimulation of astrocytic 5-HT2B receptors change multiple gene expressions/editings and metabolism of glutamate, glucose and glycogen: a potential paradigm shift. Front Behav Neurosci (2015) 0.89
Lack of serotonin reuptake during brain development alters rostral raphe-prefrontal network formation. Front Cell Neurosci (2013) 0.88
Gene expression profile analysis of genes in rat hippocampus from antidepressant treated rats using DNA microarray. BMC Neurosci (2010) 0.88
5-HT 1A/1B receptor-mediated effects of the selective serotonin reuptake inhibitor, citalopram, on sleep: studies in 5-HT 1A and 5-HT 1B knockout mice. Neuropsychopharmacology (2003) 0.87
Pharmacologic treatments for the behavioral symptoms associated with autism spectrum disorders across the lifespan. Dialogues Clin Neurosci (2012) 0.86
Genetic polymorphisms in the 5-hydroxytryptamine type 3B receptor gene and paroxetine-induced nausea. Int J Neuropsychopharmacol (2007) 0.86
Sox10 regulates ciliary neurotrophic factor gene expression in Schwann cells. Proc Natl Acad Sci U S A (2006) 0.86
Pharmacotherapy of anxiety disorders: a critical review. Dialogues Clin Neurosci (2011) 0.86
CNTF-activated astrocytes release a soluble trophic activity for oligodendrocyte progenitors. Neurochem Res (2006) 0.85
Role of 5-HT(1A) receptors in fluoxetine-induced lordosis inhibition. Horm Behav (2010) 0.85
High serotonin levels during brain development alter the structural input-output connectivity of neural networks in the rat somatosensory layer IV. Front Cell Neurosci (2013) 0.85
5-HT7 receptor deletion enhances REM sleep suppression induced by selective serotonin reuptake inhibitors, but not by direct stimulation of 5-HT1A receptor. Neuropharmacology (2008) 0.84
Augmentation of SSRI effects on serotonin by 5-HT2C antagonists: mechanistic studies. Neuropsychopharmacology (2007) 0.84
Pharmacological treatment of obsessive-compulsive disorder. Psychiatr Clin North Am (2014) 0.84
White-matter relaxation time and myelin water fraction differences in young adults with autism. Psychol Med (2014) 0.83
Long-term effects on serotonin transporter mRNA expression of chronic neonatal exposure to a serotonin reuptake inhibitor. Eur J Pharmacol (1998) 0.83
Expression of ciliary neurotrophic factor (CNTF), CNTF receptor alpha (CNTFR-alpha) following experimental intracerebral hemorrhage in rats. Neurosci Lett (2005) 0.83
A comparative review of escitalopram, paroxetine, and sertraline: Are they all alike? Int Clin Psychopharmacol (2014) 0.82
The genetics of selective serotonin reuptake inhibitors. Pharmacol Ther (2012) 0.82
Spotlight on paroxetine in psychiatric disorders in adults. CNS Drugs (2002) 0.82
Exposure to serotonin adversely affects oligodendrocyte development and myelination in vitro. J Neurochem (2015) 0.81
Serotonin transporter genotype x construction stress interaction in rats. Behav Brain Res (2011) 0.81
Fluvoxamine, a selective serotonin reuptake inhibitor, and 5-HT2C receptor inactivation induce appetite-suppressing effects in mice via 5-HT1B receptors. Int J Neuropsychopharmacol (2006) 0.81
Developmental fluoxetine exposure differentially alters central and peripheral measures of the HPA system in adolescent male and female offspring. Neuroscience (2012) 0.80
The role of the hippocampus in avoidance learning and anxiety vulnerability. Front Behav Neurosci (2014) 0.80
Steps Following Attainment of Remission: Discontinuation of Antidepressant Therapy. Prim Care Companion J Clin Psychiatry (2001) 0.79
Prenatal exposure to selective serotonin reuptake inhibitors and social responsiveness symptoms of autism: population-based study of young children. Br J Psychiatry (2014) 0.78
Global state measures of the dentate gyrus gene expression system predict antidepressant-sensitive behaviors. PLoS One (2014) 0.78
Ciliary neurotrophic factor role in myelin oligodendrocyte glycoprotein expression in Cuprizone-induced multiple sclerosis mice. Cell Mol Neurobiol (2013) 0.78
Violent acts associated with fluvoxamine treatment. J Psychiatry Neurosci (2001) 0.78
The thyroid hormone, triiodothyronine, enhances fluoxetine-induced neurogenesis in rats: possible role in antidepressant-augmenting properties. Int J Neuropsychopharmacol (2009) 0.78
Developmental exposure to SSRIs, in addition to maternal stress, has long-term sex-dependent effects on hippocampal plasticity. Psychopharmacology (Berl) (2014) 0.78
Chronic fluoxetine treatment alters cardiovascular functions in unanesthetized rats. Eur J Pharmacol (2011) 0.78
Profiling of hypothalamic and hippocampal gene expression in chronically stressed rats treated with St. John's wort extract (STW 3-VI) and fluoxetine. Psychopharmacology (Berl) (2010) 0.78
Fluvoxamine exerts anorexic effect in 5-HT2C receptor mutant mice with heterozygous mutation of beta-endorphin gene. Int J Neuropsychopharmacol (2008) 0.77
Impaired fear extinction as displayed by serotonin transporter knockout rats housed in open cages is disrupted by IVC cage housing. PLoS One (2014) 0.77
Effects of 5-HT(2) receptor antagonists on the anti-immobility effects of imipramine in the forced swimming test with mice. Eur J Pharmacol (2001) 0.77
Behavioural effects of antidepressants are dependent and independent on the integrity of the dentate gyrus. Int J Neuropsychopharmacol (2010) 0.77
Developmental fluoxetine exposure increases behavioral despair and alters epigenetic regulation of the hippocampal BDNF gene in adult female offspring. Horm Behav (2016) 0.77
Clinical efficacy and safety of fluoxetine in generalized anxiety disorder in Chinese patients. Neuropsychiatr Dis Treat (2013) 0.77